2023
DOI: 10.1016/j.bbr.2022.114201
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol exerts anxiolytic-like effects through anti-inflammatory and antioxidant activities in rats exposed to chronic social isolation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
1
0
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 79 publications
0
1
0
2
Order By: Relevance
“…These results suggest that resveratrol's antidepressant‐like effects could be linked to regulating NF‐κB/NOD‐like receptor protein 3 (NLRP3) signaling pathways. Additionally, Baghaei Naeini et al (2023) demonstrated the antidepressant‐like activity of resveratrol in socially isolated rats during behavioral tests, but only at doses of 40 and 80 mg/kg (with 20 mg/kg proving inactive). This activity of resveratrol might stem from its dose‐dependent positive impact on serum corticosterone levels and hippocampal inflammatory and oxidative stress biomarkers.…”
Section: Stilbenes In Neuropsychiatric and Neurological Disordersmentioning
confidence: 99%
“…These results suggest that resveratrol's antidepressant‐like effects could be linked to regulating NF‐κB/NOD‐like receptor protein 3 (NLRP3) signaling pathways. Additionally, Baghaei Naeini et al (2023) demonstrated the antidepressant‐like activity of resveratrol in socially isolated rats during behavioral tests, but only at doses of 40 and 80 mg/kg (with 20 mg/kg proving inactive). This activity of resveratrol might stem from its dose‐dependent positive impact on serum corticosterone levels and hippocampal inflammatory and oxidative stress biomarkers.…”
Section: Stilbenes In Neuropsychiatric and Neurological Disordersmentioning
confidence: 99%
“…大量研究表明,抑郁症患者相比健康对照组TGF-β/TGF-β1水平较低,并且重度抑郁症患者血浆TGF-β1水平的降低与抑郁症状的严重程度呈负相关,提示TGF-β/TGF-β1可能成为抑郁症临床诊断及评估的生物标志物 [ 12 - 16 ] 。然而,Davami等 [ 17 ] 和Momeni等 [ 18 ] 研究显示,抑郁症患者外周血TGF-β/TGF-β1的水平显著高于健康对照组。但是,Köhler等 [ 4 ] 的荟萃分析则显示,与健康对照组比较,重度抑郁症患者外周血中TGF-β的水平无显著变化。未接受药物治疗的重度抑郁症患者与健康对照组外周血TGF-β水平无显著差异 [ 19 ] 。对抑郁症患者死后大脑眼窝前额皮质的解剖以及老年抑郁症患者脑脊液的分析研究结果也显示,TGF-β/TGF-β1水平在外周血中无显著变化 [ 20 - 21 ] 。在抑郁症模型动物中,多数研究支持TGF-β/TGF-β1水平在其大脑或脾脏中降低的趋势 [ 22 - 26 ] ,少数研究证实TGF-β1在其大脑前额皮质或海马中的表达显著增加 [ 27 - 28 ] 。上述研究结果间的差异可能是受试者群体的异质性所致。抑郁障碍是一种异质性疾病,包括单次发作的抑郁障碍、复发性抑郁障碍、恶劣心境障碍等,不同亚型患者症状严重程度、抑郁发作次数、是否伴精神症状、起病年龄及病程长短等因素都可能影响TGF-β相关基因的表达及外周血TGF-β水平的变化。此外,不同实验间测定方法及标准的差异或潜在的混杂因素(如体重指数、家族史、共病)也可能是产生异质性的原因。…”
Section: 药物干预前抑郁症与转化生长因子- β 的关系unclassified
“…与健康对照组比较,CUMS模型大鼠抑郁行为明显,海马神经元严重受损,TGF-β阳性表达显著下调,用大剂量左归降糖解郁方可减轻其神经元损伤,上调海马TGF-β蛋白表达,改善大鼠抑郁样行为 [ 24 , 44 ] 。相反,逍遥散 [ 27 ] 和补肾疏肝方 [ 28 ] 通过调节CUMS小鼠海马TGF-β1/Smad信号通路导致 TGF - β1 mRNA表达降低而发挥抗抑郁作用。在具有抗抑郁作用的植物提取物相关研究中,乔松素可通过增加海马 TGF - β mRNA的表达改善神经炎症和细胞凋亡来改善CUMS引起的抑郁样行为 [ 2 ] 。与乔松素类似,栀子苷可升高CUMS小鼠额叶皮层中 TGF - β mRNA表达 [ 23 ] ,但白藜芦醇反而下调TGF-β在抑郁模型大鼠海马体中的表达 [ 26 ] 。四羟基二苯乙烯-2- O -β- D -葡糖苷是从何首乌中分离得到的主要有效成分,具有广泛的药理活性;TGF-β/Smad信号通路可介导四羟基二苯乙烯-2- O -β- D -葡糖苷的抗抑郁治疗途径,具有显著的抗炎、神经保护、增强记忆力等药理活性 [ 45 ] 。…”
Section: 药物干预对抑郁症转化生长因子- β 水平的影响unclassified
“…Depression and chronic illness have a reciprocal effect, as is increasingly apparent. Studies have revealed that depression can promote or exacerbate the symptoms of chronic illness in people who live with chronic illness (Baghaei Naeini et al, 2023;Ford, 2008;Zarebavani et al, 2023).…”
Section: Introductionmentioning
confidence: 99%